IART Integra LifeSciences Holdings Corporation

Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)

Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)

New global medical education platform offers digital tools to keep HCPs at the forefront of medical knowledge

PRINCETON, N.J., Jan. 14, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the launch of its global medical education platform . This new digital resource is designed to elevate Integra’s medical education offerings in surgical, neurologic, ENT and regenerative care​ by enhancing professional development through a wealth of on-demand learning resources.

The Integra Institute platform is designed for healthcare providers (HCPs) in the United States and EMEA across multiple medical specialties, tailored to a variety of experience levels. The curated hub includes on-demand webinars on complex medical scenarios​, surgical videos showcasing the latest techniques and best practices​ and an events calendar for continuous learning and networking.

“Integra is a longstanding partner to HCPs who work on complex procedures with a profound impact on patients’ lives. We are proud to build on our strong partnerships with this community by developing a premier, one-stop-shop in professional education,” said Kristen Hedstrom, Integra’s vice president of professional education and divisional market access.

“HCPs often look for efficient, digital tools to stay up to date with the latest guidance in our fields and advance patient outcomes. I am excited about the Integra Institute and its facilitation of convenient learning and collaboration across the industry,” said Dr. Said Azoury, plastic and reconstructive surgeon and assistant professor of surgery at the Hospital of the University of Pennsylvania.

Interested clinicians can explore the site by registering for an account at: .

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit

Contacts:

Media

Laurene Isip



Investor Relations

Chris Ward





EN
14/01/2025

Underlying

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financi...

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) --   (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Reported revenues were $434.9 million, representing a decrease of 1.7% on a reported basis and 2.5% on an organic basis compared to the fourth quarter of 2024. GAAP earnings per diluted share were $(0.02), compared to $0.25 in the fourth quarter of 2024.Adjusted earnings per diluted shar...

 PRESS RELEASE

Integra LifeSciences Announces Key Executive Leadership Appointments

Integra LifeSciences Announces Key Executive Leadership Appointments Executive team further strengthened with appointments of Teshtar Elavia to the newly created chief technology officer role, Michael Hutchinson as chief legal officer, and Kerri DiPietro as chief quality officer, representing decades of experience in the MedTech industry PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead...

 PRESS RELEASE

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financi...

Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026 PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on th...

 PRESS RELEASE

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Mor...

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m ET or 11:15 a.m PT A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under . Abo...

 PRESS RELEASE

Integra LifeSciences Leadership to Present at the Citi 2025 Global Hea...

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under . About Integra LifeSciencesAt Integra LifeSc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch